A group of Republicans and Democrats in the House and Senate is asking the Health Resources and Services Administration (HRSA) to finalize regulations around drug ceiling prices and penalties for manufacturers that overcharge the 340B program.
Category: Uncategorized
Payer Roundup—UnitedHealthcare may buy Genoa; Mississippi quietly amends work requirements
Specialty pharmacy operator Genoa could be worth as much as much as $2.5 billion. Meanwhile, a rule CMS recently proposed could prevent people from becoming home healthcare workers, even though the U.S. will soon need millions more.
Addressing the Complex Needs of Medicare Beneficiaries: The CHRONIC Care Act
Whether it’s installing a wheelchair ramp or grab bar for the bathroom, people with complex health and social needs often benefit from interventions beyond medicine. Bruce Chernof, M.D., President and CEO of The SCAN Foundation, explores what health pl…
